PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 82 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,940,881 | -65.4% | 536,024 | -42.7% | 0.00% | -66.7% |
| Q2 2023 | $25,851,242 | +135566.4% | 935,961 | +13.0% | 0.01% | +28.6% |
| Q1 2023 | $19,055 | +384.1% | 828,471 | +129.7% | 0.01% | +250.0% |
| Q4 2022 | $3,936 | -99.9% | 360,714 | +6.5% | 0.00% | +100.0% |
| Q3 2022 | $2,854,000 | +6.7% | 338,544 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $2,674,000 | +13.7% | 337,972 | +11.1% | 0.00% | 0.0% |
| Q1 2022 | $2,351,000 | +26.8% | 304,112 | +26.8% | 0.00% | 0.0% |
| Q4 2021 | $1,854,000 | +47.0% | 239,929 | +47.1% | 0.00% | – |
| Q3 2021 | $1,261,000 | -1.9% | 163,086 | -1.9% | 0.00% | – |
| Q2 2021 | $1,286,000 | +15.0% | 166,325 | +14.9% | 0.00% | – |
| Q1 2021 | $1,118,000 | +28.5% | 144,700 | +28.5% | 0.00% | – |
| Q4 2020 | $870,000 | -0.7% | 112,571 | -0.6% | 0.00% | – |
| Q3 2020 | $876,000 | +25.0% | 113,297 | +24.8% | 0.00% | – |
| Q2 2020 | $701,000 | +0.1% | 90,772 | -8.4% | 0.00% | – |
| Q1 2020 | $700,000 | -48.9% | 99,073 | -49.0% | 0.00% | -100.0% |
| Q4 2019 | $1,370,000 | -24.2% | 194,437 | +29.2% | 0.00% | 0.0% |
| Q3 2019 | $1,808,000 | +284.7% | 150,531 | +287.2% | 0.00% | – |
| Q2 2019 | $470,000 | – | 38,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |